Treatment sequencing and considerations between lines of therapy in Multiple Myeloma
Insights from expert discussions provide an overview of current perspectives on treatment sequencing and factors to consider between established lines of therapy.
The content reflects how treatment decisions in multiple myeloma may be influenced by a range of elements, including patient characteristics, prior therapies, and the evolving treatment landscape, highlighting the complexity of clinical decision-making in this setting.
Video 1: Considerations about sequensing in the treatment of multiple myeloma with Professor Elena Zamagni and Professor Marc S. Raab.
Video 2: The role of immune rest in immunotherapy when treating multiple myeloma with Professor Elena Zamagni and Professor Marc S. Raab.